Skip to main content
SpringerLink
Log in

Toxic Retinopathies

  • Chapter
  • First Online:
Microperimetry and Multimodal Retinal Imaging

  • 900 Accesses

Abstract

Although few data have been published on this topic, microperimetry should be considered a specific and sensitive tool for screening patients who are taking potentially toxic medication. The comparison with other functional exams and the integration of the results is helpful in the early diagnosis of retinal damage, as well as in the follow-up of these patients. Microperimetry is not yet considered a routine procedure in the management of toxic retinopathies, but the information obtained are essential to ensure a tailored decision about the need to discontinue the drug preventing permanent vision loss.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hobbs HE, Sorsby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478–480

    Article  CAS  PubMed  Google Scholar 

  2. Stelton CR, Connors DB, Walia SS et al (2013) Hydrochloroquine retinopathy: characteristic presentation with review of screening. Clin Rheumatol 32:895–898

    Article  PubMed  Google Scholar 

  3. Marmor MF, Kellner U, Lai TY et al (2011) Revised recommendation on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422

    Article  PubMed  Google Scholar 

  4. Marmor MF, Carr RE, Easterbrook M et al (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109:1377–1382

    Article  PubMed  Google Scholar 

  5. Marmor MF (2012) Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 130:461–469

    Article  CAS  PubMed  Google Scholar 

  6. Hart VM, Burde RM, Johnston GP et al (1984) Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression. Arch Ophthalmol 102:377–380

    Article  PubMed  Google Scholar 

  7. Kelmerson AT, Brar VS, Murthy RK et al (2010) Fundus autofluorescence and spectral domain optical coherence tomography in early detection of plaquenil maculopathy. Eur J Ophthalmol 20:785–788

    Google Scholar 

  8. Angi M, Romano V, Valldeperas X et al (2010) Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient. Int Ophthalmol 30:195–197

    Article  PubMed  Google Scholar 

  9. Banin E, Shalev RS, Obolensky A et al (2003) Retinal function abnormalities in patients treated with vigabatrin. Arch Ophthalmol 121:811–816

    Article  CAS  PubMed  Google Scholar 

  10. Nayfield SG, Gorin MB (1996) Tamoxifen-associated eye disease. A review. J Clin Oncol 14:1018–1026

    CAS  PubMed  Google Scholar 

  11. Cronin BG, Lekich CK, Bourke RD (2005) Tamoxifen therapy conveys increased risk of developing a macular hole. Int Ophthalmol 26:101–105

    Article  PubMed  Google Scholar 

  12. Kaiser-Kupfer MI, Lippman ME (1978) Tamoxifen retinopathy. Cancer Treat Rep 62:315–320

    CAS  PubMed  Google Scholar 

  13. Noureddin BN, Seoud M, Bashshur Z et al (1999) Ocular toxicity in low-dose tamoxifen: a prospective study. Eye 13:729–733

    Article  PubMed  Google Scholar 

  14. Heier JS, Dragoo RA, Enzenauer RW et al (1994) Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 117:772–775

    CAS  PubMed  Google Scholar 

  15. Eisner A, Austin DF, Samples JR (2004) Short wavelength automated perimetry and tamoxifen use. Br J Ophthalmol 88:125–130

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Watanabe SE, Berezovsky A, Motono M et al (2010) Retinal function in patients treated with tamoxifen. Doc Ophthalmol 120:137–143

    Article  PubMed  Google Scholar 

  17. Salomão SR, Watanabe SE, Berezovsky A et al (2007) Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use. Curr Eye Res 32:345–352

    Article  PubMed  Google Scholar 

  18. Cortin P, Corriveau LA, Rousseau AP et al (1982) Maculopathy with golden particles. Can J Ophthalmol 17:103–106

    CAS  PubMed  Google Scholar 

  19. Harnois C, Samson J, Malenfant M et al (1989) Canthaxanthin retinopathy. Anatomic and functional reversibility. Arch Ophthalmol 107:538–540

    Article  CAS  PubMed  Google Scholar 

  20. Hueber A, Rosentreter A, Severin M (2011) Canthaxanthin retinopathy: long-term observations. Ophthalmic Res 46:103–106

    Article  CAS  PubMed  Google Scholar 

  21. Millay RH, Klein ML, Illingsworth DR (1988) Niacin maculopathy. Ophthalmology 95:930–936

    Article  CAS  PubMed  Google Scholar 

  22. Gass JDM (1973) Nicotinic acid maculopathy. Am J Ophthalmol 76:500–510

    CAS  PubMed  Google Scholar 

  23. Spirn MJ, Warren FA, Guyer DR et al (2003) Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 135(6):913–914

    Article  PubMed  Google Scholar 

  24. Weekley RD, Potts AM, Reboton J et al (1960) Pigmentary retinopathy in patients receiving high doses of a new phenothiazine. Arch Ophthalmol 64:65–76

    Article  CAS  PubMed  Google Scholar 

  25. Borodoker N, Del Priore LV, De A, Carvalho C et al (2002) Retinopathy as a result of long-term use of thioridazine. Arch Ophthalmol 120:994–995

    Article  PubMed  Google Scholar 

  26. Chantada GL, Fandino AC, Carcaboso AM et al (2009) A phase I study of periocular topotecan in children with intraocular retinoblastoma. Invest Ophthalmol Vis Sci 50:1492–1496

    Article  PubMed  Google Scholar 

  27. Steinle JJ, Zhang Q, Thompson KE et al (2012) Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis. Invest Ophthalmol Vis Sci 53:2439–2445

    Article  PubMed  Google Scholar 

  28. Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol 47(Suppl 1):S203–S218

    Article  PubMed  Google Scholar 

  29. Rodrigues EB, Meyer CH, Mennel S et al (2007) Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27:958–970

    Article  PubMed  Google Scholar 

  30. Kriechbaum K, Prager F, Geitzenauer W et al (2009) Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology 116:2415–2421

    Article  PubMed  Google Scholar 

  31. Mylonas G, Sacu S, Dunavoelgyi R et al (2013) Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion. Retina 33:1220–1226

    Article  CAS  PubMed  Google Scholar 

  32. Koehrer P, Creuzot-Garcher C, Bron AM (2011) Methanol poisoning: two case studies of blindness in Indonesia. Int Ophthalmol 31:517–524

    Article  CAS  PubMed  Google Scholar 

  33. Ng SK, Ebneter A, Gilhotra JS (2013) Hip-implant related chorio-retinal cobalt toxicity. Indian J Ophthalmol 61:35–37

    PubMed Central  PubMed  Google Scholar 

  34. Petzold A, Plant GT (2006) Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt 26:326–341

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GB Bietti Foundation, IRCCS, Via Livenza 3, Rome, 00198, Italy

    Raffaele Parrozzani MD, PhD

  2. Department of Ophthalmology, University of Padova, Via Giustiniani 2, Padova, 35128, Italy

    Silvia Bini

Authors
  1. Raffaele Parrozzani MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Bini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raffaele Parrozzani MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Padova, Padova, Italy

    Edoardo Midena

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parrozzani, R., Bini, S. (2014). Toxic Retinopathies. In: Midena, E. (eds) Microperimetry and Multimodal Retinal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40300-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40300-2_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40299-9

  • Online ISBN: 978-3-642-40300-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation